The Effect of Cold Gel Pack Application on Itching in Burn Patients in the Maturation Stage
Trial Parameters
Brief Summary
Burn is a serious trauma that causes acute damage to the skin and subcutaneous tissues due to the effect of heat, electricity, radiation, physical, and chemical substances. It has been reported that the incidence of itching is high in burn patients during the maturation stage of wound healing. The literature suggests that in managing the symptom of itching, skin hydration support along with cold application methods can also be used. The integrity of the skin, the duration, frequency, characteristics, areas of itching, and identifying conditions that increase or decrease itching are important for managing itching. This study is planned to be conducted with a randomized controlled design to examine the effect of applying cold gel packs to burn areas of burn patients during the maturation stage on itching. This researcher's hypothesis is that burn patients who applied cold gel packs to burn areas during the maturation phase had lower itching severity (frequency, duration, intensity) than those who did not.
Eligibility Criteria
Inclusion Criteria: * Burn percentage is between 15-25% and 1st or 2nd degree burn areas are in the maturation phase (BatesJensen Wound Assessment Tool Scale score=1-13), * Describing itching in burn wounds in the last 24 hours, * Over 18 years of age, * Literate, * Oriented to person, place and time, * Having no vision, speech or communication problems, * Do not have any skin disease other than burns, * Patients whose vital signs are within physiological limits (Pulse: 60-100/min, Temperature: average 37 degrees Celsius, respiration 12-16/min, Blood Pressure: average 120/80). Exclusion Criteria: * Cold sensitivity/allergy, * Perineum, neck and inner wrist burn areas * Hypertrophic scar area, * Burn infection * Raynaud's disease, * Use of aspirin, anticoagulants, non-steriod anti-inflammatory drugs, * Evitamin and vasoactive agent use, * Peripheral vascular disease, * Connective tissue disease, * Diabetic neuropathy, * Use of a medication that will cause itching, * Patients participati